Roumai Medical - About the company
Roumai Medical is a funded company based in Shenzhen (China), founded in 2021. It operates as a Provider of next-generation artificial blood vessels for medical applications. The company has 148 active competitors, including 42 funded and 35 that have exited. Its top competitors include companies like SMT, Aortyx and Thrombolex.
Company Details
Provider of next-generation artificial blood vessels for medical applications. The company focused on developing innovative medical devices, such as tissue-engineered blood vessels for various clinical indications such as cardiovascular and cerebrovascular diseases, diabetes, and more.
Key Metrics
Founded Year
2021
Location
Shenzhen, China
Stage
Funding Raised
Investors
Ranked
188th among 190 competitors
Sign up to download Roumai Medical's company profile
Roumai Medical's funding and investors
Roumai Medical is a funded company. Roumai Medical has 1 institutional investor.
View details of Roumai Medical's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Roumai Medical's Competitors and alternates
Top competitors of Roumai Medical include SMT, Aortyx and Thrombolex. Here is the list of Top 10 competitors of Roumai Medical, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Manufacturer of minimally invasive cardiovascular devices including coronary and structural heart | $93.5M | 71/100 | ||
2nd | Developer of smart devices for aortic diseases | $15.8M | 55/100 | ||
3rd | Thrombolex 2016, Doylestown (United States), Series A | Developer of endovascular catheters for acute venous thromboembolic conditions | $67.8M | 54/100 | |
4th | Terumo Medical 1921, Shibuya (Japan), Funding Raised | Provider of a portfolio of medical devices for interventional cardiology | - | 54/100 | |
5th | Relisys Medical Devices 1997, Ranga Reddy (India), Early Stage | Provider of medical devices for cardiovascular and structural heart treatment | $21.2M | 53/100 | |
6th | Medyria 2012, Winterthur (Switzerland), Series B | Developer of technology for endovascular catheter navigation and sensing | $12.3M | 52/100 | |
7th | Echopoint Medical 2018, London (United Kingdom), Series A | Developer of smart devices for monitoring coronary artery disease and microvascular dysfunction | $9.99M | 51/100 | |
8th | Cardiovascular Systems 1989, Saint Paul (United States), Acquired | Developer of devices for treating peripheral and coronary vascular disease | $121M | 50/100 | |
9th | Experts in regenerative medicine | $5.44M | 50/100 | ||
10th | Vascular Solutions 1997, Minneapolis (United States), Acquired | Products for vascular diagnostics and interventional procedures | $12M | 50/100 | |
188th | Roumai Medical 2021, Shenzhen (China), Funding Raised | Provider of next-generation artificial blood vessels for medical applications | - | 15/100 |
Looking for more details on Roumai Medical's competitors? Click here to see the top ones
Roumai Medical's Investments and acquisitions
Roumai Medical has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Roumai Medical
Explore our recently published companies
- P Louise Cosmetics - United Kingdom based, 2018 founded, Unfunded company
- KEYKO DESIGN - Poland based, 2006 founded, Unfunded company
- Vgmatics - Sungai Buloh based, 2017 founded, Unfunded company
- SeatCorp - Kuala Lumpur based, 2017 founded, Unfunded company
- Diligentic - Calgary based, 2021 founded, Unfunded company
- Kaastrup - Denmark based, 2001 founded, Unfunded company
